Veracyte, Inc (VCYT) PT Lowered to $44 at Stephens
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 11/3/2026
- S&P 500 ends down; Apple dips ahead of quarterly report
- Apple beats quarterly estimates for profit and revenue
- Marvell agrees $115 billion all-stock deal to buy Lumentum
- Oil drops 7% as Iran signals openness to peace talks
- Palantir raises 2026 revenue outlook after quarterly revenue nearly doubles on AI
Tweet
Share
E-mailGet Alerts VCYT Hot Sheet
Price: $49.00 -2.02%
Rating Summary:
17 Buy, 5 Hold, 0 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 3 | Down: 12 | New: 3
Rating Summary:
17 Buy, 5 Hold, 0 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 3 | Down: 12 | New: 3
Join SI Premium – FREE
Stephens analyst Mason Carrico lowered the price target on Veracyte, Inc (NASDAQ: VCYT) to $44.00 (from $52.00) while maintaining a Overweight rating.
You May Also Be Interested In
- Ten Afirma Abstracts to Highlight Thyroid Nodule Diagnosis and Cancer Research at ATA 2026
- YDUQS Participacoes SA (YDUQ3:BZ) PT Lowered to R$14 at JPMorgan
- Iovanace Biotherapeutics (IOVA) PT Raised to $8 at UBS
Create E-mail Alert Related Categories
Analyst PT ChangeSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
